Clinical trial with escalating doses of the antiepidermal growth factor receptor humanized monoclonal antibody EMD 72 000 in patients with advanced squamous cell carcinoma of the larynx and…

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, June 2001

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 71 Dimensions

Readers on

mendeley: 8 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

Specific binding proteins and uses thereof

Grant US-9562102-B2

United States of America

Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof

Grant US-9283276-B2

United States of America

Use of anti-EGFR antibodies in treatment of EGFR mutant mediated disease

Grant US-9090693-B2

United States of America

Specific binding proteins and uses thereof

Grant US-9072798-B2

United States of America

Specific binding proteins and uses thereof

Application US-20130266573-A1

United States of America

NOVEL COMBINATION TREATMENT OF CANCER

Application WO-2012136829-A1

World Intellectual Property Organisation (WIPO)

Novel combination treatment of cancer

Application EP-2508176-A1

European Patent Office

IMMUNOLIPOSOMES FOR TREATMENT OF CANCER

Application WO-2009040426-A1

World Intellectual Property Organisation (WIPO)